 |
 |
PROGRAMME |
MONDAY 26 MARCH 2012 |
10.30 |
Opening of the 3rd TNO Beneficial Microbes Conference
|
10.45 |
Keynote lecture
Setting the scene: How to define a beneficial microbe? Prof.dr. Eric Claassen, VU University Amsterdam / Erasmus MC, the Netherlands
|
|
Session 1
Beneficial microbes and host-microbe communication |
Chair: |
Prof.dr. Jerry Wells
Wageningen University, the Netherlands |
11.15 |
Gate-keeper function of the epithelium
Prof.dr. Per Brandtzaeg, University of Oslo and Oslo University Hospital, Norway |
11.45 |
Inter-kingdom chemical signalling in host-bacterial associations Dr. Vanessa Sperandio, University of Texas Southwestern Medical Center, USA
|
12.15 |
Probiotic mechanism to enhance influenza vaccination
Dr. Marjolein Meijerink, Host-Microbe Interactomics, Wageningen UR, the Netherlands |
12.45 |
Contributed paper
Antimicrobial functions of intestinal Reg3ß Linda Loonen, M.Sc., TI Food & Nutrition / Wageningen UR, the Netherlands |
|
13.00 - 14.00 Lunch break |
Session 2
Effect of beneficial microbe metabolites on the host |
Chair: |
Dr. Ger Rijkers University College Roosevelt Academy, the Netherlands |
14.00 |
Function and importance of Akkermansia
spp. in the intestinal tract Clara Belzer, Laboratory of Microbiology, Wageningen UR, the Netherlands |
14.30 |
Effect of propionate on adipose metabolism
Dr. Koen Venema, TNO Healthy Living, the Netherlands |
15.00 |
Administration of butyrate producing organisms to treat IBD
Dr. Hana Kozáková, Institute of Microbiology, Academy of Sciences, Czech Republic |
15.30 |
Contributed paper Lactate produced by
Streptococcus thermophilus in intestinal tract of gnotobiotic rats may trigger goblet cells differentiation pathway: a new probiotic function?
Laura Wrzosek, Commensal and Probiotics-Host Interactions Laboratory, INRA, France |
15.45 |
Networking break |
|
Session 3 Shaping and modulating microbiotia composition
|
Chair: |
Dr. Annick Mercenier Nestlé Research Center, Switzerland
|
16.15 |
Evolution of the microbiota and the influence of diet Prof.dr. Michael Blaut, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany
|
16.45 |
Breast milk – the source of more life than we imagine
Dr. Rocio Martin, Danone Research, the Netherlands |
17.15 |
A novel approach to microbial replacement: 30 strain transplant Dr. Elaine Petrof, Oueen's University, Canada |
17.45 |
Functional foods for digestive health in dogs
Dr. Julie K. Spears, Nestlé Purina PetCare, USA |
18.15 |
Contributed paper
The ontogeny of the intestinal IgA CDR3 repertoire and IgA production in response to the gut microbiota Gerco den Hartog, Cell Biology and
Immunology Group/Adaptation Physiology Group, Wageningen UR, the Netherlands |
|
18.30 - 19.30 TNO's Lounge Party TUESDAY 27 MARCH 2012
Session 4 Mining the metagenome and microbiome of the gut
|
Chair: |
Dr. Jiro Nakayama Kyushu University, Japan
|
08.30 |
Tools to display metagenomics data William A. Walters,
Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, USA |
09.00 |
Metagenomics screening (MetaHit)
Dr. S. Dusko Ehrlich, MICA Department, INRA, France and Académie des Arts et Sciences, Croatia |
09.30 |
Asian Microbiome Project: A pilot study on the basal microbiota profile of healthy youngsters Dr. Yuan Kun Lee, Department of Microbiology, Yong
Loo Lin School of Medicine, National University of Singapore, Singapore |
10.00 |
Contributed paper
A multiscale systems biology approach to the human Bacteroides thetaiotaomicron Dr. Ines Thiele, Faculty of Industrial Engineering,
Mechanical Engineering and Computer Science, University of Iceland, Iceland |
10.15 |
Networking break |
|
Session 5 Can beneficial microbes prevent diseases?
|
Chair: |
Prof.dr. Michael Cabana
University of California, San Fransisco, USA |
10.45 |
Bifidobacteria protect the host from enteropathogenic infection through production of acetate
Dr. Hiroshi Ohno, Research Center for Allergy and Immunology, RIKEN, Japan |
11.10 |
Beneficial microbes – the link between diet and cancer risk?
Dr. Wendy S. Garrett, Department of Immunology and Infectious Diseases, Harvard School of Public Health and Dana-Farber Cancer Institute, USA
|
11.35 |
Intestinal dysbiosis in coeliac disease: is there a role for probiotics? Dr. Yolanda Sanz, Institute of Agrochemistry and Food Technology,
Spanish National Research Council (IATA-CSIC), Spain |
12.00 |
The airway microbiome in asthma and COPD
Yvonne J. Huang, Department of Medicine, University of California, San Francisco, USA |
12.25 |
Contributed paper
Influence of human gut microbiota on the metabolic fate of glucosinolates
Vijitra Luang-In, Department of Life Sciences, Imperial College London, UK |
|
12.40 - 13.30 Lunch break
Session 6 Validated in vitro and ex vivo models |
Chair: |
Dr. Koen Venema TNO, the Netherlands |
13.30 |
Organotypic co-culture models to study the effect of beneficial microbes functionally Dr. Manfred Schmolz, EDI GmbH, Germany |
14.00 |
Use of an in vitro
model to study fermentation by the microbiota Dr. Marjorie Koenen, TNO, the Netherlands |
14.30 |
Assessment of survival of probiotics under various conditions using a validated in vitro model
Thomas D. Leser, Chr. Hansen A/S, Health & Nutrition Division, Denmark |
15.00 |
A novel polarized ex vivo
organ culture model to study beneficial microbes
Dr. Katerina Tsilingiri, Department of Experimental Oncology, European Institute of Oncology, Italy |
15.30 |
Contributed paper
Glycerol supplementation boots Lactobacillus reuteri's protective effect against Salmonella typhimurium
infection in a 3-D organotypic model of colon epithelium
Rosemarie De Weirdt, Laboratory of Microbial Ecology and Technology, Ghent University, Belgium |
15.45 |
Networking break |
|
Session 7 Towards successful claims for pre-and probiotics
|
Chair: |
Dr. Gregor Reid University of Western Ontario, Canada
|
16.15 |
Beneficial microbes: claims and ethics
Dr. Diane Hoffmann, School of Law, University of Maryland, USA |
16.45 |
Critical issues for successful claim applications
Dr. Alwine Kardinaal, TNO, the Netherlands |
17.15 |
Why do we need claims on products? Consumers don't!?
Dr. Ger Rijkers,
University College Roosevelt Academy, the Netherlands |
17.45 |
Contributed paper
Primo-colonizing bacteria induce maturation of colonic epithelium in gnotobiotic rat models
Dr. Claire Cherbuy, Commensal and Probiotics-Host Interactions Laboratory, INRA, France |
|
18.00 - 19.30 Drinks during poster presentations
20.30 Conference dinner |
| |
WEDNESDAY 28 MARCH 2012
Session 8
Recent successful applications of beneficial microbes
|
Chair: |
Dr. Frédérique Chaucheyras-Durand Lallemand, France
|
08.30 |
Microbial mitigation: the Achilles' heel of allergy?
Prof.dr. Harry Wichers, Food & Biobased Research, Wageningen UR, the Netherlands |
08.50 |
Effect of B. breve
Yakult on childhood constipation – a case study Eline van Bel, Waterland Hospital, the Netherlands |
09.10 |
Probiotics for HIV subjects in the developing world
Dr. Gregor Reid, Lawson Health Research Institute and University of Western Ontario, Canada |
09.30 |
Control of bacterial diseases in aquaculture with pre- and probiotics Prof.dr. Peter Bossier, Laboratory of Aquaculture & Artemia Reference
Center, Department of Animal Production, Ghent University, Belgium |
09.50 |
Live yeast probiotics and immunomodulation in pigs
Dr. Kenneth Mellits, Division of Food Science, School of Biosciences, University of Nottingham, UK |
10.10 |
Contributed paper
Influence of probiotics on the intestinal epithelial barrier Dr. Saskia van Hemert, Winclove, the Netherlands |
10.30 |
Networking break |
|
Session 9 Future developments – new tools |
Chair: |
Dr. Koen Venema TNO, the Netherlands |
11.00 |
Drosophila as a model system to study microbiota/gut interaction
Prof. Dr. Julien Royet, Developmental Biology Institute of Marseilles – Luminy, CNRS, France |
11.30 |
A microfluidic platform for droplet-enabled co-cultivation of microbial communities Jihyang Park, M.Sc., University of Michigan, USA |
12.00 |
Single cell genomic sequencing of uncultured bacteria for the human microbiome project Prof.dr. Roger Lasken, J. Craig Venter Institute, USA
|
12.30 |
From stem-cells to self-organizing organoids Prof.dr.
Hans Clevers, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Centre Utrecht, the Netherlands
|
13.00 |
Closing of the 3rd TNO Beneficial Microbes Conference
(including a packed lunch to eat along the way!)
|
|
|
|
|
|
|
|
|
 |
Secretariat |
Bastiaanse Communication, P.O. Box 179, NL-3720 AD Bilthoven, the Netherlands |
T +31 30 2294247, F +31 30 2252910, BM@bastiaanse-communication.com |
|
|
|
|